Home > Support & Training > FDA Resource Center : Press Releases
Content Authors: Please type in your comments below on what was changed or added.
Please keep existing comments that may be there for future recordkeeping, and include a date with your
comment.
Page Content
Please type in or update your page content below.
Press Releases
Listed below are Wonderware press releases regarding Wonderware's committment to FDA's 21 CFR Part 11 requirement.
Wonderware Launches Major New Initiatives To Lower The Cost Of Implementing and Maintaining 21 CFR Part 11 FDA Validated Applications
Wonderware® Corporation, an operating unit of the Production Management Division of Invensys plc, today announced that the company has reaffirmed its commitment to meet the needs of regulated industries that must comply with U.S. Food & Drug Administration (FDA) requirements, specifically 21 CFR Part 11. Several major product and support initiatives will soon be underway from the California-based software developer…
View full story
Invensys Introduces 21 CFR Part 11 Compliance Program For Wonderware Products Used In Pharmaceutical Industries
Invensys plc today announced a comprehensive program to help pharmaceutical companies using Wonderware products comply with 21 CFR Part 11 U.S. Food and Drug Administration (FDA) regulations for electronic records and signatures. This new initiative unites the expertise of Validation Technologies—a part of the Invensys Pharmaceutical Solutions group that specializes in computer systems validation and regulatory compliance in FDA-regulated industries…
View full story
